Skip to main content

Table 3 Meta-analysis results of the association of C677T polymorphisms and HCC of 4 studies (including CLD controls)

From: Association between the methylenetetrahydrofolate reductase C677T polymorphism and hepatocellular carcinoma risk: a meta-analysis

Genetic model OR 95%CI p for herterogeneity I2 Egger's p
TT/CC (OR1) 1.72 0.84-3.52 0.04 0.64 0.69
CT/CC (OR2) 0.85 0.62-1.16 0.82 0 0.44
TT/CT (OR3) 1.81 1.22-2.71 0.25 0.28 0.71
(TT+CT)/CC 1.03 0.77-1.36 0.13 0.46 0.26
TT/(CC+CT) 1.85 1.00-3.42 0.06 0.60 0.78
CT/(CC+TT) 0.75 0.57-0.99 0.92 0 0.68
T/C 1.31 0.86-2.02 0.01 0.76 0.25